Cite
HARVARD Citation
Hoogendoorn, M. et al. (2021). Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: a model-based study. BMJ open. 11 (8), p. . [Online].